Framatome was recently awarded a contract to provide full system decontamination at Bruce Power Units 3 and 4 as part of their Major Component Replacement (MCR) project. Adapting unique chemical decontamination technology developed globally, Framatome will localize it for use by its Canadian teams in the country's CANDU reactors. The chemical process is undergoing qualification at Canadian Nuclear Labs, with current results yielding excellent results for decontamination factors.

"Our Framatome team combines global expertise and innovative adaptability as we develop our footprint in Canada and our partnership with Bruce Power," said Catherine Cornand, senior executive vice president of Installed Base for Framatome. "We are committed to help ensure the long-term operations of Canada's nuclear fleet, which provides low-cost, reliable, carbon-free electricity for citizens of Ontario and beyond."

Full system decontamination using this optimized chemical process will be performed prior to refurbishment activities on-site at Units 3 and 4 in Tiverton, Ontario, significantly mitigating the dose and enhancing safety when accessing the units.

The full system decontamination project is currently in the design and procurement phase, with expected deployment at Unit 3 in April 2023 and at Unit 4 in August 2024. To date, Framatome teams have performed the conceptual and preliminary engineering phase in support of the project. This latest contract awards the remaining detailed engineering work, which is fully supported using Framatome's Canadian engineering resources.

Framatome has successfully performed 36 full system decontamination applications globally using its chemical technology, and more than 500 decontaminations of pumps and systems since 1976.

The MCR project for Bruce Power Units 3 and 4 will add approximately 30 to 35 years of operational life, while other investments will add a combined 30 years of operational life to the units. Each one of Bruce Power's reactors can generate enough low-cost, reliable, safe and carbon-free electricity to meet the annual needs of a city the size of Ottawa, Canada, with an estimated population of 1.18 million in 2022.

Related Links
Framatome
Nuclear Power News - Nuclear Science, Nuclear Technology
Powering The World in the 21st Century at Energy-Daily.com

Tweet

Thanks for being here; We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain. With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords. Our news coverage takes time and effort to publish 365 days a year. If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor $5 Billed Once credit card or paypal		SpaceDaily Monthly Supporter $5 Billed Monthly paypal only

Isotope Production at Bruce Power produces first medical isotope
Paris, France (SPX) Jun 23, 2022
An international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company) and ITM Isotope Technologies Munich SE (ITM), announced today a milestone marking the first instance lutetium-177, a short-lived medical isotope, has been produced in a commercial nuclear power reactor. This milestone was achieved using a new Isotope Production System (IPS) that was installed in Bruce Power's Unit 7 during a recent planned maintenance outage. The IPS successfully irradiated targets to p ... read more